ANNA BURDZY: Open Payments
NPI 1922688860 · WALLINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $150 |
| Novo Nordisk Inc | 1 | $120 |
| Corcept Therapeutics | 1 | $25 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| IBSA Pharma Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $15 |
Products named: OMNIPOD, Ozempic, Korlym, The Cologuard Plus Collection Kit, Tirosint, AREXVY, REZDIFFRA.
Industry payments across NJ — which companies pay providers there.
